$993.3M in CY2024 Part D spend670K claims · 192K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Rimegepant used for?
Rimegepant is a this drug class medication tracked in Medicare Part D.
Is there a generic for Rimegepant?
No. Rimegepant is brand-only with no generic equivalents currently in market.
How much does my plan pay for Rimegepant?
Across 329 Part D plans, Rimegepant averages $128.75/unit (NADAC). Lowest available: $128.75/unit. Highest in distribution: $128.75/unit.
Is Rimegepant on the FDA shortage list?
No. Rimegepant is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.